Last reviewed · How we verify
Atorvastatin Calcium Tablets, 40 mg
At a glance
| Generic name | Atorvastatin Calcium Tablets, 40 mg |
|---|---|
| Also known as | Lipitor® 40 mg Tablets |
| Sponsor | Dr. Reddy's Laboratories Limited |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Flushing
- Pruritus
- Upper respiratory tract infection
- Constipation
- Myalgia
- Headache
- Diarrhoea
- Back pain
- Muscle spasms
- Dizziness
- Alanine aminotransferase increased
Key clinical trials
- Atorvastatin Therapy on Xanthoma in Alagille Syndrome (PHASE4)
- Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer (PHASE2)
- Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorvastatin (PHASE1)
- Combined Effects of Statins and Exercise on Training Sensitive Health Markers (NA)
- Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (PHASE4)
- A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin (PHASE1)
- Statins for the Treatment of NASH (PHASE2)
- Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: